UTMD Utah Medical Products
- 64.180
- -0.510-0.79%
- 66.040
- +1.860+2.90%
Utah Medical Products News
Utah Medical Products' (NASDAQ:UTMD) Soft Earnings Don't Show The Whole Picture
Utah Medical Products | 10-Q: Q3 2024 Earnings Report
With 66% Institutional Ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) Is a Favorite Amongst the Big Guns
Utah Medical Products GAAP EPS of $3.09, Revenue of $31.74M
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
Utah Beauty's same-store sales fell by 1.2% in the second quarter, falling short of analyst expectations.
On August 30th, Utah Beauty's same-store sales fell by 1.2%, while analysts expected growth of 1.32%. Net sales for the second quarter were $2.6 billion, with analysts expecting $2.61 billion. Net sales for the full year are expected to be $11 billion to $11.2 billion, compared to the company's original forecast of $11.5 billion to $11.6 billion. Same-store sales for the full year are expected to decline by 2% to zero growth, compared to the company's original expectation of 2%-3%, while analysts expect growth of 1.89%.
Will Weakness in Utah Medical Products, Inc.'s (NASDAQ:UTMD) Stock Prove Temporary Given Strong Fundamentals?
Utah Medical Products | 10-Q: Q2 2024 Earnings Report
Utah Medical Products To Go Ex-Dividend On September 20th, 2024 With 0.3 USD Dividend Per Share
August 2nd (Eastern Time) - $Utah Medical Products(UTMD.US)$ is trading ex-dividend on September 20th, 2024.Shareholders of record on September 20th, 2024 will receive 0.3 USD dividend per share on
Utah Medical Products Second Quarter 2024 Earnings: EPS: US$0.98 (Vs US$1.16 in 2Q 2023)
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q2 Revenue $10.4M
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal
Investors in Utah Medical Products (NASDAQ:UTMD) Have Unfortunately Lost 27% Over the Last Year
With 65% Ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) Boasts of Strong Institutional Backing
Utah Medical Products | 10-Q: Q1 2024 Earnings Report
Utah Medical Products To Go Ex-Dividend On June 14th, 2024 With 0.3 USD Dividend Per Share
May 9th - $Utah Medical Products(UTMD.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 14th, 2024 will receive 0.3 USD dividend per share on July 5th, 2024. The ex-di
Utah Medical Products First Quarter 2024 Earnings: EPS: US$1.09 (Vs US$1.16 in 1Q 2023)
Utah Medical Products GAAP EPS of $1.09, Revenue of $11.34M
Utah Medical Products (UTMD.US): The 2024 Q1 financial report achieved revenue of US$11.34 million, with a previous value of US$12.52 million; earnings per share of US$1.09, compared with a previous value of US$1.15.
Utah Medical Products (UTMD.US): The 2024 Q1 financial report achieved revenue of US$11.34 million, with a previous value of US$12.52 million; earnings per share of US$1.09, compared with a previous value of US$1.15.
Analysis
Price Target
No Data
No Data